Erratum: Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer. (American Society for Biochemistry and Molecular Biology Inc. (2014) 289 (26417-26429) DOI: 10.1074/jbc.M114.553818)

Kush Dalal, Mani Roshan-Moniri, Aishwariya Sharma, Huifang Li, Fuqiang Ban, Mohamed D. Hassona, Michael Hsing, Kriti Singh, Eric Leblanc, Scott Dehm, Emma S Tomlinson Guns, Artem Cherkasov, Paul S. Rennie

Research output: Contribution to journalComment/debatepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Erratum: Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer. (American Society for Biochemistry and Molecular Biology Inc. (2014) 289 (26417-26429) DOI: 10.1074/jbc.M114.553818)'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences